Englander Institute for Precision Medicine

Publications

Found 931 results
Author Title Type [ Year(Asc)]
2026
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Publisher Correction: Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(3):666.
Du W, De Boni L, Hopkins BDavid, Elemento O.  2026.  A quantitative approach for defining the degradability landscape of protein degraders.. Nat Commun.
Armstrong AJ, Azad AA, Iguchi T, Stenzl A, Mottet N, Russell D, Rosales M, Haas GP, Saad F, Hussain M et al..  2026.  Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.. J Clin Oncol. :JCO2402829.
Duren-Lubanski A, Podaza E, Merrit E, Tocheva AS, M Martin L, Elemento O, Hopkins BD.  2026.  A Real-Time Image-Based Co-Culture Assay to Quantify Tumor-Infiltrating Lymphocyte-Mediated Apoptotic Killing of Patient-Derived Tumor Organoids.. J Vis Exp. (235)
Annabestani M, Sriram S, Kuzemczak A, S Wong C, Sigaras A, Mosadegh B.  2026.  Real-time XR-based 6-DOF catheter tracking enhances cardiac intervention navigation efficiency and depth perception.. NPJ Biomed Innov. 3(1)
Al-Thani NM, Toor SM, Umlai U-KIsmail, Aliyu U, Suhre K, Albagha OME.  2026.  Refining the Genetic Contribution to Type 2 Diabetes Subtypes.. Diabetes Obes Metab.
Armstrong AJ, Azad AA, Saad F, Hussain M, Iguchi T, Stenzl A, Sternberg CN.  2026.  Reply to: Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.. J Clin Oncol. :JCO2601500.
Hanif SZ, Kutz C, Au CMCherie, Torregroza I, Palikhe S, Jannath SY, Fabiha T, Bhinder B, Washburn MP, Devost D et al..  2026.  Role of orphan G protein-coupled receptor GPR52 in breast cancer cell multicellular organization and collective invasion.. Br J Cancer.
Zimmerman J, Malone BF, Chu K, Finkin-Groner E, Sun S, Liang R, Bahadur S, Foronda M, Schatoff EM, Granowsky E et al..  2026.  A selective TNKS2 inhibitor for tumor-restricted WNT suppression.. Nat Chem Biol.
Maushagen J, Grune E, Schlett CL, Kiefer LSophie, Suhre K, Adamski J, Wang-Sattler R, Peters A, Bamberg F, Rospleszcz S.  2026.  Serum metabolite patterns of adipose tissue distribution and body composition subphenotypes.. Lipids Health Dis. 25(1)
Belkadi A, Thareja G, Stephan N, Halama A, Suhre K.  2026.  Size-Resolved Lipoprotein Fatty Acid Content as a Novel Nuclear Magnetic Resonance-Derived Trait Specifically Associates with Genetic Variants That Control Fatty Acid Metabolism.. J Proteome Res.
Michielsen L, Prjibelski AD, Foord C, Spiegelman Y, Kim T, Hu W, Jarroux J, Hsu J, Pfeil R, Zhang X et al..  2026.  Spatial isoform sequencing at single-cell resolution reveals cell-type-specific spatial isoform variability in multiple brain cell types.. Nat Methods. 23(9):1869-1881.
Marulanda-Corzo V, Kakkar P, Sharbatdaran A, Sternberg CN, Huicochea-Castellanos S.  2026.  Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare.. Clin Nucl Med.
Costa APaula, Acquarone E, Lazarian A, Herman M, Wartchow KM, Bartelo N, Dartora WJ, Krumsiek J, Li X-L, Baskin JM et al..  2026.  Temporal and spatial control of phosphatidylinositides using optogenetics ameliorates behavioral deficits in an Alzheimer's disease mouse model.. Commun Biol.
Nazzaro M, Mardis ER, Canella A, Bhinder B, Elemento O, Behbehani G, Currier M, Glaspell A, Lee DA, Cripe TP et al..  2026.  Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.. Mol Ther Oncol. 34(1):201147.
Elemento O, Giannakakou P.  2026.  Training the Next Generation of AI-Enabled Cancer Scientists.. Cancer Discov. :OF1-OF4.
Armstrong AJ, Morris MJ, Abida W, Aggarwal RR, Antonarakis ES, Attard G, Beltran H, Bryce A, Carducci MA, Cheng HH et al..  2026.  Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.. J Clin Oncol. :JCO2502834.
Rajendran S, Malmsten JE, Arnal LB, Meseguer M, Rosenwaks Z, Zaninovic N, Hajirasouliha I.  2026.  Trial emulation for validating the clinical efficacy of a foundational AI model in embryo selection.. NPJ Digit Med.
Podaza E, Capuano J, Kuo H-H, Assaad MAl, Markowitz G, M Revuelta V, Nguyen J, Irizarry A, Ravichandran H, Ackermann S et al..  2026.  Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC.. Cell Rep Methods. :101339.
Bartelo N, Li Y, Hao Y, Soni V, Marino J, Yang HS, Satlin MJ, Wang F, Krumsiek J, Zhao Z.  2026.  Untargeted metabolomics reveals organism specific biomarkers of carbapenem resistance in Klebsiella pneumoniae and Escherichia coli.. NPJ Syst Biol Appl.
Muthukumar T, Belkadi A, Li C, Thareja G, Yang H, Lagman M, Alonso A, Xiang JZ, Bernstein M, Mansoori HAl et al..  2026.  Urinary single-cell transcriptomics in kidney transplantation: Elucidation of donor-recipient cellular dynamics and fibrogenic stress.. Am J Transplant.
Henry O, Brumberger E, Jotwani R, Sigaras A, Sriram S, Yeh IM, Rubin J.  2026.  Using an Artificial Intelligence Conversational Agent in Virtual Reality to Teach Serious Illness Communication Skills to Residents.. J Grad Med Educ. 18(2):193-194.
Purkayastha S, Park J, Beyer S, Chandra A, Markowitz SM, Lerman BB, Elemento O, Krumsiek J, Lo JC, Cheung JW.  2026.  Utilization of Serum Metabolomics and Polygenic Risk Scores in a Novel Risk Stratification Tool for the Prediction of Incident Atrial Fibrillation.. Circ Arrhythm Electrophysiol. :e013858.
Dantas E, Hootman KC, Moyer J, Tomberlin M, Curran K, Ramesh B, Price H, Kim J, McPherson AC, Hurd MA et al..  2026.  Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study.. Nat Commun.
Assaad MAl, Hadi K, Levine MF, Guevara D, Patel M, Tranquille M, King A, Otilano J, Semaan A, Gundem G et al..  2026.  Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort.. Commun Med (Lond). 6(1):5.